Name | hypocrellin a |
---|---|
Synonyms |
1-Acetyl-2,5,12-trihydroxy-4,8,9,13-tetramethoxy-2-methyl-2,3-dihydro-1H-cyclohepta[ghi]perylene-6,11-dione
(1S,2R)-1-Acetyl-2,5,12-trihydroxy-4,8,9,13-tetramethoxy-2-methyl-2,3-dihydro-1H-cyclohepta[ghi]perylene-6,11-dione 1H-Cyclohepta[ghi]perylene-6,11-dione, 1-acetyl-2,3-dihydro-2,5,12-trihydroxy-4,8,9,13-tetramethoxy-2-methyl-, (1S,2R)- 1H-Cyclohepta[ghi]perylene-6,11-dione, 1-acetyl-2,3-dihydro-2,5,12-trihydroxy-4,8,9,13-tetramethoxy-2-methyl- hypocrellin |
Description | Hypocrellin A, a naturally occurring PKC inhibitor, has many biological and pharmacological properties, such as antitumour, antiviral, antibacterial, and antileishmanial activities. Hypocrellin A is a promising photosensitizer for anticancer photodynamic therapy (PDT)[1][2][3][4]. |
---|---|
Related Catalog | |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 894.0±65.0 °C at 760 mmHg |
Melting Point | 245-250ºC |
Molecular Formula | C30H26O10 |
Molecular Weight | 546.521 |
Flash Point | 299.6±27.8 °C |
Exact Mass | 546.152588 |
PSA | 148.82000 |
LogP | 3.42 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.737 |
Safety Phrases | 22-24/25 |
---|